100
Participants
Start Date
July 27, 2021
Primary Completion Date
June 30, 2024
Study Completion Date
June 30, 2024
FB825
A humanized monoclonal immunoglobulin G1 (IgG1) targeting the CεmX domain on human B lymphocytic cells expressing membrane-bound IgE (mIgE).
Placebo
Formulation buffer
RECRUITING
Chiayi Chang Gung Memorial Hospital, Chiayi City
RECRUITING
Kaohsiung Chang Gung Medical Foundation, Kaohsiung City
RECRUITING
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
RECRUITING
Far Eastern Memorial Hospital, New Taipei City
RECRUITING
China Medical University Hospital, Taichung
RECRUITING
Taichung Venterans General Hospital, Taichung
RECRUITING
National Cheng Kung University Hospital, Tainan City
RECRUITING
Linkou Chang Gung Memorial Hospital, Taipei
RECRUITING
MacKay Memorial Hospital, Taipei
RECRUITING
Ministry of Health and Welfare Shuang-Ho Hospital, Taipei
RECRUITING
National Taiwan University Hospital Hsin-Chu Branch, Taipei
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
Taipei Medical University Hospital, Taipei
RECRUITING
Taipei Municipal Wanfang Hospital, Taipei
RECRUITING
Taipei Veterans General Hospital, Taipei
RECRUITING
Tri-Service General Hospital, Taipei
Lead Sponsor
Microbio Shanghai Co., Ltd.
UNKNOWN
Oneness Biotech Co., Ltd.
INDUSTRY